Abstract
308nm xenon-chloride excimer laser, a novel mode of phototherapy, is an ultraviolet B radiation system consisting of a noble gas and halide. The aim of this systematic review was to investigate the literature and summarize all the experiments, clinical trials and case reports on 308-nm excimer laser in dermatological disorders. 308-nm excimer laser has currently a verified efficacy in treating skin conditions such as vitiligo, psoriasis, atopic dermatitis, alopecia areata, allergic rhinitis, folliculitis, granuloma annulare, lichen planus, mycosis fungoides, palmoplantar pustulosis, pityriasis alba, CD30+ lympho proliferative disorder, leukoderma, prurigo nodularis, localized scleroderma and genital lichen sclerosus. Although the 308-nm excimer laser appears to act as a promising treatment modality in dermatology, further large-scale studies should be undertaken in order to fully affirm its safety profile considering the potential risk, however minimal, of malignancy, it may impose.
Keywords: excimer, laser, dermatology
Introduction
Excimer laser in which “excimer” is a terminological reference of “excited dimer”, composed of a noble gas and halide which repel each other, has turned into a prevalent mode of action in confronting numerous skin disorders 1. Of these ultraviolet B rays which comprise beams of varied wavelengths, the 308nm xenon-chloride is the most practical in dermatology 1. The advantages of monochromatic excimer laser over phototherapies of other kinds have been depicted as lower UV dose exposure, shorter course of therapy and for the most part, the possibility of being directed at distinct sites of skin rather than compromising the adjacent normal skin 2, 3, 4. The aim of this overview of excimer laser was to summarize all reported uses of this kind of laser in different dermatologic diseases.
Vitiligo
Vitiligo is an acquired depigmentary disorder characterized by white areas on the skin due to loss of functional melanocytes 5, 6. Medium doses of the 308-nm excimer laser has proved to be effective in the treatment of limited vitiligo, however, the rate and speed of repigmentation is highly associated with the site and duration of disease as the face and neck (UV sensitive areas) are the highly respondent areas along with an earlier resolution of the lesions while the joints and extremities (UV resistant areas) exhibit the slightest response to therapy 7- 10. Also, the shorter disease course is more promising in the treatment results 11. Additionally, trials have demonstrated further efficacy of treatment in Fitzpatrick skin types other than I and II 12, 13. Combination therapy of the 308-nm excimer laser and calcineurin inhibitors, topical tacrolimus in particular, is regarded to be more beneficial than excimer laser alone 14, 15 as well as combination therapy with topical tacalcitol 16. On the other hand, simultaneous use of topical calcipotriol has not indicated superior outcomes 17. It has also demonstrated efficacy in treating childhood vitiligo 18 which is evidently intensified at simultaneous use of topical pimecrolimus 19. Being compared to narrow-band UVB phototherapy (311- 313 nm), 308-nm excimer laser seems to augment and expedite the repigmentation process 20, 21. Treatment outcomes of the 308-nm excimer lamp was akin to that of the 308-nm excimer laser 22, 23.
Psoriasis
Psoriasis is a common, chronic, disfiguring inflammatory and proliferative disorder of the skin 24, 25. Notable abrogation of psoriasis plaques has been noted even following the first session of excimer laser phototherapy which also sustains subsequent to treatment tapering 26, 27. It has shown to be efficacious in the management of psoriasis vulgaris, scalp and palmoplantar psoriasis 28-31 and child psoriasis as well 32. Being administered with other modes of phototherapy (PUVA: psoralen UVA) or topical treatments (flumetasone, dithranol, calcipotriol; each applied in combination therapy individually), 308-nm excimer laser exhibited higher efficacy than monotherapy 33-35. The 308-nm excimer lamp and the 308-nm excimer laser did not indicate any considerable differences in terms of efficacy 36.
Atopic dermatitis
Atopic dermatitis is a chronic relapsing skin disease characterized by xerosis and pruritus 37. 308-nm excimer laser should be considered as a beneficial treatment modality in localized atopic dermatitis both in adults and children 38- 39. It also appears to be more effective than clobetasol propionate in overcoming prurigo form of atopic dermatitis 40.
Alopecia areata
Both 308-nm excimer lamp and 308-nm excimer laser provoke regrowth of hair in patchy alopecia areata in children and adults, with the utmost effect on the scalp lesions in spite of no detectable changes in the lesions of extremities 41- 44.
Allergic rhinitis
Regarding the immunosuppressive aspect of phototherapy, 308-nm excimer laser was appraised in the treatment of allergic rhinitis which evidently diminished the hypersensitivity symptoms such as rhinorrhea, sneezing and total nasal score 45-46.
Folliculitis
Substantial improvement was detected following sessions of 308-nm excimer laser therapy in refractory folliculitis 47.
Granuloma annulare
In a case report presenting a 73-year old female with long-standing granuloma annulare, thorough clearance of the lesions was obtained after undergoing sessions of 308-nm excimer laser therapy 48.
Lichen planus
Lichen planus is an inflammatory papulosquamous disorder of the skin 49. Significant resolution of erosive oral lichen planus was achieved on account of low-dose 308-nm excimer laser treatment 50, 51.
Mycosis fungoides
Receiving 308-nm excimer laser as a mode of therapy has shown promising results in early-stage localized mycosis fungoides 52, 53. Moreover, combination therapy of 308-nm excimer laser, psoralen ultraviolet A (PUVA) and oral bexarotene has set the stage for considerable remission of mycosis fungoides plaques in a case report 54.
Palmoplantar pustulosis
Application of 308-nm excimer laser brought about remission of palmoplantar pustulosis on top of increasing the levels of regulatory T cells 55 .
Pityriasis Alba
Profound improvement of Pityriasis Alba was discerned following 308-nm excimer laser phototherapy with no significant adverse events 56 .
CD30+ lymphoproliferative disorder
There is a case report of a primary CD30+ lymphoproliferative nodule in which profitable advancement was noted secondary to 308-nm excimer laser therapy 57.
Leukoderma
A case report presenting an HIV positive male who developed leukoderma of lower face due to amyl-nitrite exposure gained near-complete resolution of the lesions as a result of 308-nm excimer laser treatment 58.
Prurigo nodularis, Localized scleroderma, Genital lichen sclerosus
Additionally, monochromatic excimer laser has been reported to contribute to marked improvement whilst confronting prurigo nodularis, localized scleroderma and genital lichen sclerosus 59. To sum up, the 308-nm excimer laser should be considered a valuable treatment option when challenging diverse skin disorders both in terms of efficacy and safety; however larger investigations with long-term follow-up need to be conducted in order to thoroughly corroborate its use.
Please cite this article as follows:
Mehraban S, Feily A. 308nm Excimer Laser in Dermatology. J Lasers Med Sci 2014;5(1):8-12
References
- 1.Spencer JM, Hadi SM. The excimer lasers. J Drugs Dermatol. 2004;3:522–5. [PubMed] [Google Scholar]
- 2.Grema H, Raulin C. The excimer laser in dermatology and esthetic medicine. Hautarzt. 2004;55:48–57. doi: 10.1007/s00105-003-0638-7. [DOI] [PubMed] [Google Scholar]
- 3.Mavilia L, Mori M, Rossi R, Campolmi P, Puglisi Guerra A, Lotti T. 308 nm monochromatic excimer light in dermatology: personal experience and review of the literature. G Ital Dermatol Venereol. 2008;143:329–37. [PubMed] [Google Scholar]
- 4.Morita A, Weiss M, Maeda A. Recent developments in phototherapy: treatment methods and devices. Recent Pat Inflamm Allergy Drug Discov. 2008;2:105–8. doi: 10.2174/187221308784543665. [DOI] [PubMed] [Google Scholar]
- 5.Feily A, Baktash D, Mohebbipour A, Feily A. Potential advantages of simvastatin as a novel anti-vitiligo arsenal. Eur Rev Med Pharmacol Sci. 2013;17:1982–3. [PubMed] [Google Scholar]
- 6.Feily A, Pazyar N. Why vitiligo is associated with fewer risk of skin cancer?: providing a molecular mechanism. Arch Dermatol Res. 2011;303:623–4. doi: 10.1007/s00403-011-1165-5. [DOI] [PubMed] [Google Scholar]
- 7.Wang HW, Zuo YG, Jin HZ, Liu YH, Ma DL, Jiang GT. et al. Efficacy and safety of 308 nm excimer laser for vitiligo. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009;31:34–6. [PubMed] [Google Scholar]
- 8.Shen Z, Gao TW, Chen L, Yang L, Wang YC, Sun LC. et al. Optimal frequency of treatment with the 308-nm excimer laser for vitiligo on the face and neck. Photomed Laser Surg. 2007;25:418–27. doi: 10.1089/pho.2007.2086. [DOI] [PubMed] [Google Scholar]
- 9.Ostovari N, Passeron T, Zakaria W, Fontas E, Larouy JC, Blot JF. et al. Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response. Lasers Surg Med. 2004;35:152–6. doi: 10.1002/lsm.20057. [DOI] [PubMed] [Google Scholar]
- 10.Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P. The efficacy of excimer laser (308 nm) for vitiligo at different body sites. J Eur Acad Dermatol Venereol. 2006;20:558–64. doi: 10.1111/j.1468-3083.2006.01547.x. [DOI] [PubMed] [Google Scholar]
- 11.Zhang XY, He YL, Dong J, Xu JZ, Wang J. Clinical efficacy of a 308 nm excimer laser in the treatment of vitiligo. Photodermatol Photoimmunol Photomed. 2010;26(3):138–42. doi: 10.1111/j.1600-0781.2010.00509.x. [DOI] [PubMed] [Google Scholar]
- 12.Hadi SM, Spencer JM, Lebwohl M. The use of the 308- nm excimer laser for the treatment of vitiligo. Dermatol Surg. 2004;30:983–6. doi: 10.1111/j.1524-4725.2004.30302.x. [DOI] [PubMed] [Google Scholar]
- 13.Al-Otaibi SR, Zadeh VB, Al-Abdulrazzaq AH, Tarrab SM, Al-Owaidi HA, Mahrous R. et al. Using a 308- nm excimer laser to treat vitiligo in Asians. Acta Dermatovenerol Alp Panonica Adriat. 2009;18:13–9. [PubMed] [Google Scholar]
- 14.Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30:130–5. doi: 10.1111/j.1524-4725.2004.30058.x. [DOI] [PubMed] [Google Scholar]
- 15.Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP. et al. Topical tacrolimus and the 308- nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol. 2004;140:1065–9. doi: 10.1001/archderm.140.9.1065. [DOI] [PubMed] [Google Scholar]
- 16.Lu-yan T, Wen-wen F, Lei-hong X, Yi J, Zhi-zhong Z. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo. Photodermatol Photoimmunol Photomed. 2006;22:310–4. doi: 10.1111/j.1600-0781.2006.00250.x. [DOI] [PubMed] [Google Scholar]
- 17.Goldinger SM, Dummer R, Schmid P, Burg G, Seifert B, Läuchli S. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol. 2007;21:504–8. doi: 10.1111/j.1468-3083.2006.02016.x. [DOI] [PubMed] [Google Scholar]
- 18.Cho S, Zheng Z, Park YK, Roh MR. The 308- nm excimer laser: a promising device for the treatment of childhood vitiligo. Photodermatol Photoimmunol Photomed. 2011;271:24–9. doi: 10.1111/j.1600-0781.2010.00558.x. [DOI] [PubMed] [Google Scholar]
- 19.Hui-Lan Y, Xiao-Yan H, Jian-Yong F, Zong-Rong L. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol. 2009;26(3):354–6. doi: 10.1111/j.1525-1470.2009.00914.x. [DOI] [PubMed] [Google Scholar]
- 20.Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, Leone G. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo- -a multicentre controlled study. J Eur Acad Dermatol Venereol. 2007;21:956–63. doi: 10.1111/j.1468-3083.2007.02151.x. [DOI] [PubMed] [Google Scholar]
- 21.Hong SB, Park HH, Lee MH. Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study. J Korean Med Sci. 2005;20:273–8. doi: 10.3346/jkms.2005.20.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Le Duff F, Fontas E, Giacchero D, Sillard L, Lacour JP, Ortonne JP. et al. Le Duff F, Fontas E, Giacchero D, Sillard L, Lacour JP, Ortonne JP, et al308-nm excimer lamp vs308- nm excimer laser for treating vitiligo: a randomized study. Br J Dermatol. 2010;163(1):188–92. doi: 10.1111/j.1365-2133.2010.09778.x. [DOI] [PubMed] [Google Scholar]
- 23.Shi Q, Li K, Fu J, Wang Y, Ma C, Li Q, e al. Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo--a randomized bilateral comparison study. Photodermatol Photoimmunol Photomed. 2013;29(1):27–33. doi: 10.1111/phpp.12015. [DOI] [PubMed] [Google Scholar]
- 24.Feily A, Pazyar N, Khazanee A, Ghassemi MR, Rafiee E, Safarpoor M. Potential advantages of topical phenytoin as a novel anti psoriasis arsenal. Niger J Med. 2011;20:296–7. [PubMed] [Google Scholar]
- 25.Feily A, Namazi MR. Cissampelos sympodialis Eichl (Menispermaceae) leaf extract as a possible novel and safe treatment for psoriasis. Sao Paulo Med J. 2009;127:241–2. doi: 10.1590/s1516-31802009000400011. [DOI] [PubMed] [Google Scholar]
- 26.Asawanonda P, Anderson RR, Chang Y, Taylor CR. 308- nm excimer laser for the treatment of psoriasis: a doseresponse study. Arch Dermatol. 2000;136:619–24. doi: 10.1001/archderm.136.5.619. [DOI] [PubMed] [Google Scholar]
- 27.Housman TS, Pearce DJ, Feldman SR. A maintenance protocol for psoriasis plaques cleared by the 308 nm excimer laser. J Dermatolog Treat. 2004;15:94–7. doi: 10.1080/09546630310021947. [DOI] [PubMed] [Google Scholar]
- 28.Han L, Somani AK, Huang Q, Fang X, Jin Y, Xiang LH, Zheng ZZ. Evaluation of 308-nm monochromatic excimer light in the treatment of psoriasis vulgaris and palmoplantar psoriasis. Photodermatol Photoimmunol Photomed. 2008;24:231–6. doi: 10.1111/j.1600-0781.2008.00364.x. [DOI] [PubMed] [Google Scholar]
- 29.Goldinger SM, Dummer R, Schmid P, Prinz Vavricka M, Burg G, Lauchli S. Excimer laser versus narrow-band UVB (311 nm) in the treatment of psoriasis vulgaris. Dermatology. 2006;213:134–9. doi: 10.1159/000093852. [DOI] [PubMed] [Google Scholar]
- 30.Nisticò SP, Saraceno R, Stefanescu S, Chimenti S. A 308-nm monochromatic excimer light in the treatment of palmoplantar psoriasis. J Eur Acad Dermatol Venereol. 2006;20:523–6. doi: 10.1111/j.1468-3083.2006.01503.x. [DOI] [PubMed] [Google Scholar]
- 31.Taylor CR, Racette AL. A 308-nm excimer laser for the treatment of scalp psoriasis. Lasers Surg Med. 2004;34:136–40. doi: 10.1002/lsm.10218. [DOI] [PubMed] [Google Scholar]
- 32. Pahlajani N, Katz BJ, Lozano AM, Murphy F, Gottlieb A. Comparison of the efficacy and safety of the 308 nm excimer laser for the treatment of localized psoriasis in adults and in children: a pilot study. Pediatr Dermatol 2005. [DOI] [PubMed]
- 33.Trott J, Gerber W, Hammes S, Ockenfels HM. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions. Eur J Dermatol. 2008;18(1):55–60. doi: 10.1684/ejd.2008.0311. [DOI] [PubMed] [Google Scholar]
- 34.Dong J, He Y, Zhang X, Wang Y, Tian Y, Wang J. Clinical efficacy of flumetasone/salicylic acid ointment combined with 308-nmexcimer laser for treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed. 2012;28(3):133–6. doi: 10.1111/j.1600-0781.2012.00654.x. [DOI] [PubMed] [Google Scholar]
- 35.Rogalski C, Grunewald S, Schetschorke M, Bodendorf MO, Kauer F, Simon JC, Paasch U. Treatment of plaque-type psoriasis with the 308 nm excimer laser in combination with dithranol or calcipotriol. Int J Hyperthermia. 2012;28:184–90. doi: 10.3109/02656736.2011.647942. [DOI] [PubMed] [Google Scholar]
- 36.Köllner K, Wimmershoff MB, Hintz C, Landthaler M, Hohenleutner U. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Br J Dermatol. 2005;152:750–4. doi: 10.1111/j.1365-2133.2005.06533.x. [DOI] [PubMed] [Google Scholar]
- 37.Feily A, Namazi MR. Vitamin A + D ointment is not an appropriate emollient for atopic dermatitis. Dermatitis. 2010;21:174–5. [PubMed] [Google Scholar]
- 38.Nisticò SP, Saraceno R, Capriotti E, Felice CD, Chimenti S. Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults and children. Photomed Laser Surg. 2008;26:14–8. doi: 10.1089/pho.2007.2116. [DOI] [PubMed] [Google Scholar]
- 39.Baltás E, Csoma Z, Bodai L, Ignácz F, Dobozy A, Kemény L. Treatment of atopic dermatitis with the xenon chloride excimer laser. J Eur Acad Dermatol Venereol. 2006;20:657–60. doi: 10.1111/j.1468-3083.2006.01495.x. [DOI] [PubMed] [Google Scholar]
- 40.Brenninkmeijer EE, Spuls PI, Lindeboom R, van der Wal AC, Bos JD, Wolkerstorfer A. Excimer laser vsclobetasol propionate 0·05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot . Br J Dermatol. 2010;163:823–31. doi: 10.1111/j.1365-2133.2010.09858.x. [DOI] [PubMed] [Google Scholar]
- 41.Ohtsuki A, Hasegawa T, Komiyama E, Takagi A, Kawasaki J, Ikeda S. 308-nm Excimer Lamp for the Treatment of Alopecia Areata: Clinical Trial on 16 Cases. Indian J Dermatol. 2013;58:326. doi: 10.4103/0019-5154.113954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Al-Mutairi N. 308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol. 2009;26:547–50. doi: 10.1111/j.1525-1470.2009.00980.x. [DOI] [PubMed] [Google Scholar]
- 43.Al-Mutairi N. 308-nm excimer laser for the treatment of alopecia areata. Dermatol Surg. 2007;33:1483–7. doi: 10.1111/j.1524-4725.2007.33320.x. [DOI] [PubMed] [Google Scholar]
- 44.Ohtsuki A, Hasegawa T, Ikeda S. Treatment of alopecia areata with 308-nm excimer lamp. J Dermatol. 2010;37:1032–5. doi: 10.1111/j.1346-8138.2010.00942.x. [DOI] [PubMed] [Google Scholar]
- 45.Kemény L, Koreck A. Ultraviolet light phototherapy for allergic rhinitis. J Photochem Photobiol B. 2007;87:58–65. doi: 10.1016/j.jphotobiol.2007.01.001. [DOI] [PubMed] [Google Scholar]
- 46.Csoma Z, Ignacz F, Bor Z, Szabo G, Bodai L, Dobozy A. et al. Intranasal irradiation with the xenon chloride ultraviolet B laser improves allergic rhinitis. J Photochem Photobiol B 2004. 2004;8(75):137–44. doi: 10.1016/j.jphotobiol.2004.05.001. [DOI] [PubMed] [Google Scholar]
- 47.Nisticò SP, Saraceno R, Carboni I, Chimenti S. Treatment of folliculitis with monochromatic excimer light (308 nm) Dermatology. 2009;218:33–6. doi: 10.1159/000165627. [DOI] [PubMed] [Google Scholar]
- 48.Bronfenbrener R, Ragi J, Milgraum S. Granuloma annulare treated with excimer laser. J Clin Aesthet Dermatol. 2012;5:43–5. [PMC free article] [PubMed] [Google Scholar]
- 49.Omidian M, Ayoobi A, Mapar MA, Feily A, Cheraghian B. Efficacy of sulfasalazine in the treatment of generalized lichen planus: randomized double-blinded clinical trial on 52 patients. J Eur Acad Dermatol Venereol. 2010;24:1051–4. doi: 10.1111/j.1468-3083.2010.03583.x. [DOI] [PubMed] [Google Scholar]
- 50.Trehan M, Taylor CR. Low-dose excimer 308- nm laser for the treatment of oral lichen planus. Arch Dermatol. 2004;140:415–20. doi: 10.1001/archderm.140.4.415. [DOI] [PubMed] [Google Scholar]
- 51.Köllner K, Wimmershoff M, Landthaler M, Hohenleutner U. Treatment of oral lichen planus with the 308-nm UVB excimer laser--early preliminary results in eight patients. Lasers Surg Med. 2003;33:158–60. doi: 10.1002/lsm.10202. [DOI] [PubMed] [Google Scholar]
- 52.Nisticò S, Costanzo A, Saraceno R, Chimenti S. Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides. Br J Dermatol. 2004;151:877–9. doi: 10.1111/j.1365-2133.2004.06178.x. [DOI] [PubMed] [Google Scholar]
- 53.Meisenheimer JL. Treatment of mycosis fungoides using a 308-nm excimer laser: two case studies. Dermatol Online J. 2006;12(7):11. [PubMed] [Google Scholar]
- 54.Huang J, Cowper S, Moss J, Girardi M. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides. J Drugs Dermatol. 2013;12:487–9. [PubMed] [Google Scholar]
- 55.Furuhashi T, Torii K, Kato H, Nishida E, Saito C, Morita A. Efficacy of excimer light therapy (308 nm) for palmoplantar pustulosis with the induction of circulating regulatory T cells. Exp Dermatol. 2011;20:768–70. doi: 10.1111/j.1600-0625.2011.01316.x. [DOI] [PubMed] [Google Scholar]
- 56.Al-Mutairi N, Hadad AA. Efficacy of 308-nm xenon chloride excimer laser in pityriasis alba. Dermatol Surg. 2012;38:604–9. doi: 10.1111/j.1524-4725.2011.02223.x. [DOI] [PubMed] [Google Scholar]
- 57.Meisenheimer JL. Novel use of 308-nm excimer laser to treat a primary cutaneous CD30+ lymphoproliferative nodule. J Drugs Dermatol. 2007;6:440–2. [PubMed] [Google Scholar]
- 58.Vine K, Meulener M, Shieh S, Silverberg NB. Vitiliginous lesions induced by amyl nitrite exposure. Cutis. 2013;91:129–36. [PubMed] [Google Scholar]
- 59.Nisticò SP, Saraceno R, Schipani C, Costanzo A, Chimenti S. Different applications of monochromatic excimer light in skin diseases. Photomed Laser Surg. 2009;27:647–54. doi: 10.1089/pho.2008.2317. [DOI] [PubMed] [Google Scholar]